Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F, Kaufmann
V, Restine S, Hawk L, Niaura R, Berrettini WH: The role of functional genetic
variation in the dopamine D2 receptor (DRD2) in response to bupropion and
nicotine replacement therapy for tobacco dependence: results of two randomized
clinical trials. Neuropsychopharmacology, in press.
Dahl JP, Weller A, Kampman KM, Oslin DW, Lohoff FW, Ferraro TN, O’Brien CP,
Berrettini WH: Association between a polymorphism in the promoter region of
the prodynorphin gene and cocaine dependence. Am J Med Genet 139:106-8, 2005.
Ferraro TN, Golden GT, Smith GG, Martin JF, Schwebel CL, Doyle GA, Buono RJ,
Berrettini WH: Confirmation of a major QTL influencing oral morphine intake in
C57 and DBA mice using reciprocal congenic strains. Neuropsychopharmacology
Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH:
Confirmation of association between the Val66Met polymorphism in the brain-
derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am J Med Genet